Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?
Fujino
Hiromichi
H
Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721-0207, USA.
Regan
John W
JW
D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000096:biosynthesis*; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000378:metabolism* / Q000502:physiology; D015290:Second Messenger Systems / Q000502:physiology*
C113936:PTGIR protein, human; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; C034671:prostaglandin F2alpha receptor; D019869:Phosphatidylinositol 3-Kinases